Evaluating the cost-benefit profile of CPI stem cell therapy necessitates a comprehensive perspective. Supporters often emphasize the possibility for significant therapeutic benefits, particularly in ailments where conventional therapies have proven inadequate. However, crucially important to assess the significant financial expenditure associated